Neurocrine Biosciences at ACT 2026

Nov 15–18, 2026 San Antonio, TX ~1.4k attendees Website

Neurocrine Biosciences takes part in 2 sessions at ACT 2026 in San Antonio. Its program centres on the Food and Drug Administration's 2025 roadmap to reduce animal use, and how far that policy has moved into practice in antibody platform development.

OrganizationACT 2026 Attendance
◆Gold Supporter
neurocrine.com
Biotech companiesGold Supporter
Biopharmaceutical company developing treatments for neurological, psychiatric, endocrine and immune disorders.
Session
Tue Nov 17
2:00pm–5:00pm
From Policy to Practice: Progress on the FDA’s 2025 Roadmap to Reduce Animal Use in Antibody Platform Development (S12)
New approach methods · Regulatory · with Lilly
  1. 2:00pmWelcome and Overview (S12-1)Neurocrine Biosciences
  2. 2:05pmA Brief History of Regulatory Efforts to Reduce Animal Use in Drug Development (S12-2)Lilly
  3. 2:20pmThe FDA Roadmap and Adoption of NAMs for Regulatory Decision Making (S12-3)U.S. Food and Drug Administration
  4. 2:50pmIndustry Experience: DruSafe/BioSafe Survey (S12-4)Agios Pharmaceuticals
  5. 3:45pmNAM Qualification Pathway for an ISTAND Drug Development Tool (S12-5)Integral Molecular
Talk
Tue Nov 17
2:00pm–2:05pm
Part of From Policy to Practice: Progress on the FDA’s 2025 Roadmap to Reduce Animal Use in Antibody Platform Development (S12)
Welcome and Overview (S12-1)
New approach methods

Explore the full ACT 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in San Antonio. Leave your work email and we’ll be in touch.

Privacy

Download the full ACT 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Neurocrine Biosciences

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American College of Toxicology (ACT). Organization details are derived from ACT’s published program, exhibitor floor plan and supporter list, and each organization’s own website. Submit a correction